What is he best known for?
The fields of study he is best known for:
Claude Granier mainly investigates Biochemistry, Peptide sequence, Peptide, Epitope and Monoclonal antibody.
His work in Biochemistry tackles topics such as Antibody which are related to areas like Molecular biology.
His research integrates issues of Protein secondary structure, Nucleus, Antigen, Polyclonal antibodies and Thyroglobulin in his study of Peptide sequence.
His study deals with a combination of Peptide and Twin-arginine translocation pathway.
Claude Granier interconnects Computational biology and Bioinformatics in the investigation of issues within Epitope.
His Monoclonal antibody research is multidisciplinary, incorporating perspectives in Phage display and Recombinant DNA.
His most cited work include:
- A peptide mimetic of an anti-CD4 monoclonal antibody by rational design (980 citations)
- Neurotensin: specific binding to synaptic membranes from rat brain (232 citations)
- Neurotensin Binding to Extraneural and Neural Receptors: Comparison with Biological Activity and Structure—Activity Relationships (130 citations)
What are the main themes of his work throughout his whole career to date?
Claude Granier mainly focuses on Biochemistry, Epitope, Antibody, Molecular biology and Peptide.
His is involved in several facets of Biochemistry study, as is seen by his studies on Peptide sequence, Toxin, Venom, Amino acid and Binding site.
The Epitope study combines topics in areas such as Antivenom, Computational biology, Monoclonal antibody and Polyclonal antibodies.
His Antibody research incorporates elements of Recombinant DNA, Antigen and Virology.
His research in Molecular biology intersects with topics in T cell, Titer, Immunoglobulin light chain, Bovine serum albumin and Linear epitope.
In his research, Biological activity is intimately related to Apamin, which falls under the overarching field of Peptide.
He most often published in these fields:
- Biochemistry (41.31%)
- Epitope (34.27%)
- Antibody (33.33%)
What were the highlights of his more recent work (between 2005-2020)?
- Epitope (34.27%)
- Antibody (33.33%)
- Biochemistry (41.31%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Epitope, Antibody, Biochemistry, Epitope mapping and Peptide.
Claude Granier has included themes like Molecular biology, Computational biology, Monoclonal antibody and Venom in his Epitope study.
His work carried out in the field of Molecular biology brings together such families of science as Toxin and Western blot.
The study incorporates disciplines such as Haemophilia A, Recombinant DNA and Virology in addition to Antibody.
In general Biochemistry, his work in Peptide sequence, Lectin and Binding site is often linked to Plasma Serine Protease Inhibitor linking many areas of study.
His studies deal with areas such as Amino acid, Alanine, Snake venom, C2 domain and Stereochemistry as well as Peptide.
Between 2005 and 2020, his most popular works were:
- Assay for Measurement of Intact B-Type Natriuretic Peptide Prohormone in Blood (116 citations)
- Discontinuous epitope prediction based on mimotope analysis (91 citations)
- PEPOP: Computational design of immunogenic peptides (70 citations)
In his most recent research, the most cited papers focused on:
Claude Granier focuses on Epitope, Biochemistry, Epitope mapping, Peptide sequence and Antibody.
Claude Granier combines subjects such as Protein structure, Computational biology and Venom with his study of Epitope.
When carried out as part of a general Biochemistry research project, his work on Binding site and Actin is frequently linked to work in Destrin and Cofilin, therefore connecting diverse disciplines of study.
His Peptide sequence study incorporates themes from Molecular biology and Polyclonal antibodies.
As part of the same scientific family, Claude Granier usually focuses on Antibody, concentrating on Recombinant DNA and intersecting with Toxin, Escherichia coli and Immunoassay.
His research on Antigen frequently links to adjacent areas such as Peptide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
